Stock data
Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals plc (JAZZ) reported revenue of US$4.27B and net income of -US$356.15M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$4.27B | — | -US$430.24M | -US$356.15M | — |
| 2024 | US$4.07B | — | US$716.63M | US$560.12M | — |
| 2023 | US$3.83B | — | US$578.58M | US$414.83M | — |
| 2022 | US$3.66B | — | -US$65.53M | -US$224.06M | — |
| 2021 | US$3.09B | — | US$170.28M | -US$329.67M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$1.21B | US$192.80M | — |
| 2026-03-31 | US$1.07B | US$293.10M | — |
| 2025-12-31 | US$1.20B | US$203.44M | — |
| 2025-09-30 | US$1.13B | US$251.41M | — |
| 2025-06-30 | US$1.05B | -US$718.50M | — |
| 2025-03-31 | US$897.80M | -US$92.50M | — |
| 2024-12-31 | US$1.09B | US$191.12M | — |
| 2024-09-30 | US$1.05B | US$215.06M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.